Skip to main content

Table 1 Patient characteristics and clinical features

From: Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma

Variable

Patients (%)

MST(mon)

Log-rank P value

HR (95%CI)

Age (years)

    

   ≤50

105(40.9)

14.93

0.493

1.00

   >50

152(59.1)

12.47

 

1.10(0.84-1.45)

Tumor stage

    

   I

44(17.1)

45.80

 

1.00

   II

34(13.2)

18.57

< 0.001

2.48(1.36-4.53)

   III

149(58.0)

11.07

 

3.46(2.14-5.61)

   IV

30(11.7)

9.07

 

4.66(2.59-8.37)

Surgical operation

    

   No

53(20.6)

6.20

0.005

1.00

   Yes

204(79.4)

15.50

 

0.61(0.44-0.86)

Chemotherapy or radiotherapy

    

   No

31(12.1)

9.00

0.803

1.00

   Yes

226(87.9)

13.30

 

0.94(0.59-1.51)

  1. Abbreviation: MST, median survival time; HR, hazard ratio; CI, confidence interval.